Literature DB >> 20621101

Upregulation of Bcl2 inhibits apoptosis-driven BAX insertion but favors BAX relocalization in mitochondria.

O Teijido1, L Dejean.   

Abstract

Protein-protein interactions between the Bcl2 family proteins regulate apoptosis. An imbalance of this interaction network due to the upregulation of the proto-oncogene Bcl2 leads to a resistance to apoptosis associated with tumor formation. Bcl2 overexpression inhibits BAX oligomerization and mitochondrial outer membrane (MOM) permeabilization. However, Bcl2 effects on earlier steps of BAX-mediated apoptosis are not fully understood. Bcl2 overexpression inhibits BAX insertion into the MOM but spontaneously increases BAX relocalization to the mitochondria. Also, a physical interaction between BAX and Bcl2 is necessary for these two effects to occur. Taken together, these results suggest upregulated Bcl2 stabilizes BAX loose binding to mitochondrial membranes, inhibiting its insertion into the MOM and consequently cytochrome c release. Copyright (c) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621101     DOI: 10.1016/j.febslet.2010.07.002

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  The dynamics of Bax channel formation: influence of ionic strength.

Authors:  Vidyaramanan Ganesan; Timothy Walsh; Kai-Ti Chang; Marco Colombini
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

2.  Hesperidin ameliorates trichloroethylene-induced nephrotoxicity by abrogation of oxidative stress and apoptosis in wistar rats.

Authors:  Aisha Siddiqi; Sana Nafees; Summya Rashid; Sarwat Sultana; Bano Saidullah
Journal:  Mol Cell Biochem       Date:  2015-05-21       Impact factor: 3.396

Review 3.  The therapeutic potential of mitochondrial channels in cancer, ischemia-reperfusion injury, and neurodegeneration.

Authors:  Pablo M Peixoto; Laurent M Dejean; Kathleen W Kinnally
Journal:  Mitochondrion       Date:  2011-03-23       Impact factor: 4.160

4.  Melamine induces Ca2+-sensing receptor activation and elicits apoptosis in proximal tubular cells.

Authors:  Allen J Yiu; Cliff-Lawrence Ibeh; Sanjit K Roy; Bidhan C Bandyopadhyay
Journal:  Am J Physiol Cell Physiol       Date:  2017-04-05       Impact factor: 4.249

5.  ST08 Altered NF-κB Pathway in Breast Cancer Cells In Vitro as Revealed by miRNA-mRNA Analysis and Enhanced the Effect of Cisplatin on Tumour Reduction in EAC Mouse Model.

Authors:  Snehal Nirgude; Sagar Desai; Raghunandan Mahadeva; Febina Ravindran; Bibha Choudhary
Journal:  Front Oncol       Date:  2022-05-09       Impact factor: 5.738

6.  Mitochondria-related gene expression changes are associated with fatigue in patients with nonmetastatic prostate cancer receiving external beam radiation therapy.

Authors:  Chao-Pin Hsiao; Dan Wang; Aradhana Kaushal; Leorey Saligan
Journal:  Cancer Nurs       Date:  2013 May-Jun       Impact factor: 2.592

7.  miR-519 regulates the proliferation of breast cancer cells via targeting human antigen R.

Authors:  Lili Ren; Yong Li; Qun Zhao; Liqiao Fan; Bibo Tan; Aimin Zang; Hua Yang
Journal:  Oncol Lett       Date:  2019-12-20       Impact factor: 2.967

8.  Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents.

Authors:  Junrong Song; Junjie Lan; Chao Chen; Shengcao Hu; Jialei Song; Wulin Liu; Xueyi Zeng; Huayong Lou; Yaacov Ben-David; Weidong Pan
Journal:  Medchemcomm       Date:  2018-05-04       Impact factor: 3.597

9.  Up regulation of Bax and down regulation of Bcl2 during 3-NC mediated apoptosis in human cancer cells.

Authors:  Mohammad Hassan Naseri; Majid Mahdavi; Jamshid Davoodi; Saeed Hesami Tackallou; Mahdi Goudarzvand; Shima Hallaj Neishabouri
Journal:  Cancer Cell Int       Date:  2015-05-28       Impact factor: 5.722

Review 10.  Mitochondrial Ion Channels in Cancer Transformation.

Authors:  Stephen M Madamba; Kevin N Damri; Laurent M Dejean; Pablo M Peixoto
Journal:  Front Oncol       Date:  2015-06-04       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.